NexGel, Inc. (NXGL)
5.03
+0.27
(+5.67%)
USD |
NASDAQ |
Oct 23, 16:00
4.78
-0.25
(-4.97%)
After-Hours: 20:00
NexGel Enterprise Value : 8.709M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 8.709M |
| October 22, 2026 | 8.578M |
| October 21, 2026 | 8.830M |
| October 20, 2026 | 8.854M |
| October 19, 2026 | 9.082M |
| October 16, 2026 | 8.980M |
| October 15, 2026 | 8.781M |
| October 14, 2026 | 8.917M |
| October 13, 2026 | 8.233M |
| October 12, 2026 | 8.117M |
| October 09, 2026 | 8.212M |
| October 08, 2026 | 7.724M |
| October 07, 2026 | 7.988M |
| October 06, 2026 | 7.946M |
| October 05, 2026 | 7.918M |
| October 02, 2026 | 7.957M |
| October 01, 2026 | 8.000M |
| September 30, 2026 | 7.945M |
| September 29, 2026 | 7.976M |
| September 28, 2026 | 7.996M |
| September 25, 2026 | 7.957M |
| September 24, 2026 | 8.810M |
| September 23, 2026 | 8.870M |
| September 22, 2026 | 8.935M |
| September 21, 2026 | 8.838M |
| Date | Value |
|---|---|
| September 18, 2026 | 8.847M |
| September 17, 2026 | 8.781M |
| September 16, 2026 | 8.676M |
| September 15, 2026 | 8.996M |
| September 14, 2026 | 8.992M |
| September 11, 2026 | 9.093M |
| September 10, 2026 | 9.083M |
| September 09, 2026 | 9.165M |
| September 08, 2026 | 9.153M |
| September 04, 2026 | 9.339M |
| September 03, 2026 | 9.561M |
| September 02, 2026 | 9.639M |
| September 01, 2026 | 9.742M |
| August 31, 2026 | 9.749M |
| August 28, 2026 | 9.683M |
| August 27, 2026 | 9.663M |
| August 26, 2026 | 9.722M |
| August 25, 2026 | 9.722M |
| August 24, 2026 | 9.955M |
| August 21, 2026 | 9.47M |
| August 20, 2026 | 10.03M |
| August 19, 2026 | 10.19M |
| August 18, 2026 | 9.999M |
| August 17, 2026 | 9.911M |
| August 14, 2026 | 11.75M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 207.10B |
| Align Technology, Inc. | 10.03B |
| AngioDynamics, Inc. | 501.34M |
| Accuray, Inc. | 162.02M |
| Alphatec Holdings, Inc. | 2.205B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.606M |
| Revenue (Quarterly) | 3.686M |
| Total Expenses (Quarterly) | 7.321M |
| EPS Diluted (Quarterly) | -8.066 |
| Gross Profit Margin (Quarterly) | 30.09% |
| Profit Margin (Quarterly) | -97.83% |
| Earnings Yield | -285.2% |
| Normalized Earnings Yield | -317.02 |